2014
DOI: 10.1016/j.amjcard.2014.05.039
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of Plasma Copeptin as a Biomarker to Predict the Therapeutic Effectiveness of Metoprolol for Postural Tachycardia Syndrome in Children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
36
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(36 citation statements)
references
References 25 publications
0
36
0
Order By: Relevance
“…Moreover, copeptin levels were shown to be positively correlated to severity of lower respiratory tract infection, and high levels of copeptin predicted poor long‐term prognosis in patients with chronic heart failure . We have extended previous evidence showing the association between copeptin and clinical problems in pediatric samples to CM exposure – a well‐known risk factor for a variety of diseases later in life.…”
Section: Discussionmentioning
confidence: 88%
“…Moreover, copeptin levels were shown to be positively correlated to severity of lower respiratory tract infection, and high levels of copeptin predicted poor long‐term prognosis in patients with chronic heart failure . We have extended previous evidence showing the association between copeptin and clinical problems in pediatric samples to CM exposure – a well‐known risk factor for a variety of diseases later in life.…”
Section: Discussionmentioning
confidence: 88%
“…A trend for higher AVP in the supine position was also observed in the OH group. The higher AVP may be a reflection of a chronically lower BP, as has been suggested when copeptin was used as an indirect measure of chronically elevated AVP (59). The increase in AVP may be due to lower pressures in the OH group compared with the syncope group at the time of the hormonal measurement, given that syncope occurred later in the HUT.…”
Section: Discussionmentioning
confidence: 94%
“…Future studies may include measuring copeptin levels to further elucidate this question. Copeptin, a stable component of AVP, is a marker of treatment effectiveness for OI, with lower levels of copeptin observed in patients effectively treated with vasoconstrictors (59). Whether OI, Aldo, or AVP/copeptin may also serve as biomarkers for the development of hypertension in this patient population warrants further attention, particularly in light of the absence of long-term cardiovascular longitudinal studies in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…The finding of a greater increase in AVP during orthostasis in patients with POTS may have physiological basis in that a low blood volume is a well-known strong stimulus for AVP release. Of possible clinical relevance relating to these findings, copeptin levels have been suggested to predict the outcome of treatment with midodrine hydrochloride27 and β-blockers in children with POTS 28…”
Section: Discussionmentioning
confidence: 99%